Sofia Kounenaki Efraimoglou

Chairperson of the Board

Mrs. Sophia Kounenaki-Efraimoglou is Vice President of the Board of Directors of the Foundation of the Hellenic World, Chairman & Managing Director of Ardittos Holdings SA – a company of the Foundation of the Hellenic World, Head of “Hellenic Cosmos” Cultural Centre and Member of the Board of Directors of Athens Exchange Group. She is Elected President of the National Chamber Network of Greek Women Entrepreneurs, as well as Treasurer of the BoD at ALBA Graduate Business School. In 2008, as a Board Member at SEV, she initiated and led the developing of the Hellenic Corporate Governance Code as well as the subsequent establishment of the Greek Corporate Governance Council in 2012. She serves as board member to various bilateral business councils and national associations, while she is also a member of the Business Advisory Council of the MBA International Program of the Athens University of Economics and Business. Mrs. Kounenaki-Efraimoglou has been President and CEO of Vivodi Telecom and President of Fortius Finance Securities S.A., companies which she both founded. She holds undergraduate and postgraduate Degrees in Philosophy, Psychology, Business Administration, Finance and Computer Programming and speaks English, French and Italian. She has been awarded among others by the Region of Attica for her outstanding entrepreneurship, as well as the Navy, the Hellenic National Defense General Staff, the Unesco Club and the Tourism Awards Organization for her service to the country. In 2022, she has been appointed President of the Athens Chamber of Commerce and Industry, being the first chairwoman elected.

Loukia Lavida

Board Vice President

Born in Athens, Loukia “Vana” Lavidas holds a B.Sc. in Economics from Deree College in Athens and an MBA from La Verne University. She is fluent in English and French. After a long experience in charity foundations and especially after serving for nine years as Secretary General of ELPIDA (Friend’s Association of Children with Cancer),  she co-founded the Muscular Dystrophy Association (MDA Hellas), an Association for the care and welfare of those with neuromuscular disorders in Greece. Since its establishment in 2000, she serves as President of the Board. During its 22 years of operations, MDA Hellas has founded three fully equipped clinics in major public hospitals in Athens, Salonica and Patras, aiming at the provision of specialized services. Moreover, the Association has founded and operates with own means the “Home of MDA”, a fully accessible space at the center of Athens that provides for education, amusement and therapeutic gymnastics to peopled with muscular disorders. Today, MDA Hellas supports more than 1.400 family across Greece. She is also a Trustee member of the American College (ACG) and a board member of the Friends of National Art Gallery in Athens.

Telemaque Jean Lavidas

Chief Executive Officer

Born in New York, USA and raised in Athens, Greece, Telemaque holds a BA economics degree from Columbia University, NY. In 2003, he joined Lavipharm Laboratories, the R&D arm in the USA, as Assistant Project Manager. In 2006, he assumed the position of Business Development Director and in 2009 he returned to Greece, where up to 2013 he managed all commercial operations of the Group as Chief Commercial Officer (CCO), responsible for five Business Units (BUs), Pharma Rx, ConsumerHealth, International, Wholesaling and 3rd Party Logistics, and pharmacy network services (Pharma PLUS). In 2013, he founded Mediterra, a fast-growing health food company based in NY. In 2021, he returned to Greece and he took helm of the Lavipharm Group, serving as Executive Board Member and since 2024 as Chief Executive Officer. He is fluent in Greek, English, French. Since 2022, he is a member of the Hellenic Entrepreneurs Association (EENE).

Telemaque Lavidas represents the 4th generation of the Lavidas family in Greece, while he continues to perpetuate the pharmaceuticals business know-how successfully.

Panagiotis Giannouleas

Deputy Chief Executive Officer

Born in Piraeus, he holds a B.Sc. in Computer Science & Engineering from La Verne University, California, U.S.A.. He started his career in 1996 at Boehringer Ingelheim Hellas as a Medical Representative, he then became Head of the CRM & Business Planning Department, and at a young age he was promoted to Sales Manager for the local market. In 2008, he moved to Angelini Pharma Hellas as Marketing and Sales Manager. Since 2012 and for 7 years he served as the General Manager of the company in Greece and Bulgaria. In 2019, he joined Lavipharm as Chief Operations Officer & Country Manager of the Group and in 2024 he was elected in the Board of Directors assuming the responsibilities of Deputy CEO. He has served as a board member of the Federation of Companies active in selfcare medicines, while he is an elected board member of SFEE (Hellenic Association of  Pharmaceutical Companies). In 2024, he co-chaired the organising committee of the 3-day EEFAM conference on pharmaceutical management.

Christos Diamandopoulos

Non-Executive Board Member

Born in Athens, Professor Christos Diamandopoulos holds a PhD in Administrative Science from  the University of Pennsylvania, USA, (full scholarship) a Master’s’ degree in France from the Universite de Paris II (Sorbonne), full scholarship,  and a BA from the National and Kapodistriakon University of Athens. He has worked internationally both in the scientific and professional areas. In Greece, he served as special advisor to the Prime Minister of the Hellenic Republic. He has also worked for many years as an advisor on financial, administrative and managerial affairs in large industries and multinational companies. He has lectured for many years in the National School of Public Administration (Organisation of State and Project Management), of which he has also been one of the founding members in 1985. He has also lectured at the Democritus, University of Thrace (Human Resources Administration, Organisation models and Political Economy), at the Kapodistriako University of Athens (Decision Making Systems and Human Resources Administration), and at the University of Peloponese (Strategic Planning and Economics in Master’s’ Degree level). He is also responsible for all research programs of the Research Institute of the University of Athens, Institute for European Integration. He has published many studies on organisation, economic methodology and history of economic thought in miscellaneous scientific journals as well as newspapers and online sources. He speaks fluently English, French and German. Today is a permanent member of the Scientific Committee in Economic Research at the “Ludwig von Mises Institute Europe” (the Austrian Academia of Scientists) in Vienna and Brussels.

James Christopoulos

Independent, Non-Executive Board Member

Mr. James Christopoulos is Senior Managing Director at CVC Capital Partners, whom he joined in 2014. CVC Capital Partners is one of the largest investment funds in the world, managing over $120 billion in capital, with a global presence. CVC has a long-standing track record and expertise investing in healthcare services and, in Greece, is the majority shareholder of Metropolitan Hospital, IASO General and Hygeia Group (Hygeia, Mitera, Leto) through its subsidiary Hellenic Healthcare SA. Prior to joining CVC, Mr. Christopoulos worked for ten years at Investcorp International, Inc., where he led investments in services companies. Previously he was in the leveraged finance team at UBS. Mr. Christopoulos holds a bachelor’s degree in Economics from Columbia University, NY and is fluent in Greek, English, French and German.

Vicky D. Kefalas

Independent, Non-Executive Board Member

Vicky D. Kefalas was born in New York, USA in 1969 and holds a B.A. in Economics from the City University of New York and an M.B.A. in Finance from Pace University also in New York. Ms Kefalas has a long track record in finance and investments, in European financing instruments, in innovation and sustainable investments, as well as in representing shareholder interests in complex, international transactions.

Ms Kefalas is a member of the Investment Committee of InvestEU Fund of the European Commission, a member of the Board of the European Innovation Council in Brussels and a member of the Governing Board of the European Institute of Innovation & Technology (EIT) in Budapest, combing significant experience in European policy, affairs, venture, debt and equity capital financing.

Also, Ms Kefalas has formerly served on the Investment Committee of the European Fund for Strategic Investments (EFSI) and has been a member of the World Economic Forum’s Global Future Council on Infrastructure. During her career since 1992, Ms Kefalas has served on senior corporate posts at British Petroleum, Athens International Airport, Ellaktor Group and at CCC, as well as on the BoD of the Athens Urban Transport Organization (OASA).

Corporate Secretary has been appointed Ms. Eleana Nikolopoulou,  Group Head of Legal & Compliance.

Born in Athens, she is Attorney at Law, admitted in the Athens Bar Association, graduate of National & Kapodistrian University of Athens Law School (LLB), Ludwig Maximilian University of Munich (LL.M), accredited Mediator and DPO. She started her professional career in 2000 as legal advisor at construction company HOCHTIEF AG involved in the New Athens International Airport Project. Following its completion, she expertise in the field of banking and insurance market as legal counsel of Eurobank, Eurolife and Viva Wallet. She is fluent in English, German and French.

(The term of the above members of the Board ends on 09/07/2027.)